Efficacy of antiplatelets in deep venous thrombosis

0
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

Complementary medicines: Heart failure

0
Heart failure (HF), also referred to as congestive cardiac failure, is present in 1–2% of the Australian population.1 It is the end result of...

The impact of air pollution

0
Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...

Inside a multidisciplinary antenatal vaccination clinic

0
To protect pregnant women and their unborn babies from the severe adverse outcomes associated with the virus, the first pharmacist-led COVID-19 vaccination clinic for pregnant women opened in Western Australia’s King Edward Memorial Hospital on 20 September.

Psychotropic self-poisoning on the rise in youth

0
A new retrospective cohort study has found that self-poisoning, by ingesting psychotropic medicines, in Australian children and adolescents is increasing. The prescribed medicines...

New Parliamentary Friendship Group champions safer medicines use

0
The PSA has supported the launch of the inaugural Parliamentary Friends of Safe and Quality Use of Medicines event, using the opportunity to call...